Table 2.
Deteriorative adipokines for atherosclerosis
Adipokines | Major function | Rank of evidence | References |
---|---|---|---|
Leptin |
↑piHDL, Lp(a) and apoB100 ↓T-cell helper type 1 response ↑FoxP3 expression and Treg cell function ↑caveolin-1, ERK1/2, eNOS in ECs ↑AngII, ROS, JNK, caveolin-1 in smooth cells ↑TSP-1 |
**** | [53–59, 61, 204, 205] |
Chemerin |
↑chemerin ∞ ↑ high-sensitivity CRP, IL6, TNF-α, resistin, leptin, BMI, TG, hypertension, ∞ ↓ HDL-C ↑chemerin ∞ ↑ Gensini score ↓chemerin → ↓atherosclerosis, TNFα,IL1β in Apoe−/− mice |
*** | [67–70] |
Resistin |
↑ lipid profile,↑ insulin resistance, ↑TG ↑ macrophages polarization, ↑TNF-α, ↑IL-1β, ↑IL-6, ↑VCAM-1, ↑VSMCs, ↑MCP-1, ↑monocyte-endothelial adhesion |
**** | [71–78] |
FABP4 |
∞ a cluster of metabolic and inflammatory risk factors ↓levels of the adipocyte fatty acid binding protein 4, insulin sensitivity ∞↓cholesterol ester accumulation and inflammatory responses |
*** | [90–92, 206–212] |
IL-1β |
expression of various cytokines, chemokines, adhesion molecules ↑leukocytes↑ platelet adhesion to collagen and thrombin↑ VCAM-1↑MCP-1 recruitment↑∞IL-10 produce↓ SMC proliferation↑ and macrophage proliferation in plaques ↑ vascular smooth muscle cell calcium deposition ↑ smooth muscle markers ↑ intimal proliferation↑ advance atherosclerosis: outward remodeling, SMC- and collagen-fibrous cap↑ |
***** | [95, 97–106, 213, 214] |
IL-18 |
cholesterol efflux (lipoprotein cholesterol↑ serum cholesterol↑) oxidative stress ↑ endothelial dysfunction |
* | [110, 111] |
IL18r no differences in atherogenesis induct MMP-9 to promote plaque rupture involve IFN-γ-dependent mechanism to develop atherosclerosis combine with IL-17 promote the diagnostic value of CT |
*** | [112–118] | |
IL-6 |
↑IL-6 ∞ macrophage infiltration in plaque ↑ anti-inflammatory cytokines level in plaques ↑ recruitment of inflammatory cells to the atherosclerotic plaque↑ ↑IL-6 ∞ SMC↑ ↑IL-6 ∞ lipid content ↑ TG ↑ LDL ↑ lipid accumulation↓ |
**** | [121, 122, 126, 215] |
IL-6−/−∞lesion formation↑MMP-9↓pro-inflammatory cytokines↑ IL-6−/−∞serum cholesterol↑ |
** | [119, 120] | |
IFN-γ |
↓ plaque destabilization,↑ foam cell,↑macrophage activity, ↑oxidative stress,↓IFN-γ∞↓ macrophage, ↓IFN-γ∞↓T lymphocyte ↑mini-TrpRS, ↑VSMC, ↑monocyte adhesion, ↓ECs glucose metabolism, ↑IFN-γ∞↑ECs dysfunction |
*** | [127, 128, 130, 131, 133, 135–138] |
TNF-α |
↑pro-atherosclerotic factors, such as ICAM-1, VCAM-1, MCP-1 the paracrine ring between adipose cells and macrophages ↑the migration and proliferation of medial smooth muscle cells ↑the transcytosis of lipoproteins (e.g., LDL) across endothelial cells and macrophages ↑the intracellular cAMP level and the expression level of SRA co-activation of NF-κB and PPAR-γ ↑ DNA binding of Osf2, AP1, CREB and ↑vascular calcification |
**** | [141–149] |
PAI-1 |
↑neointima formation ↑fibrin(ogen) accumulation; ↑thrombosis ↑cell proliferation and SMCs senescence ↑macrophage invasion |
**** | [151–155, 158] |
RBP4 |
↑macrophage cholesterol uptake and foam cell formation ↑RBP4 serum levels in patients with established carotid atherosclerosis∞ the severity of atherosclerosis |
** | [161, 162] |
LCN2 |
↓the stimulatory effect of lipopolysaccharide on cytokine gene expression ↑the development of aortic atherosclerotic lesions ↑intraplaque monocyte/macrophage infiltration and pentraxin-3 and collagen-1 expressions ↑ the production of IL6 ↑IL-8 ↑ monocyte chemotactic protein-1 in human macrophages ↑human coronary artery smooth muscle cells ↑ THP1 monocyte adhesion to HUVECs accompanied with upregulation of intercellular adhesion molecule-1 ↑vascular cell adhesion molecule-1 ↑E-selectin associated with nuclear factor-κB (NF-κB) upregulation |
*** | [163, 166, 167] |
∞↓Plaque size | [216] |
Rank of evidence: Weak (*), moderate (**), strong (***), stronger (****), Strongest (*****)